Welcome to the new Gustave Roussy website
A new website designed to offer you a simpler, clearer, and more intuitive experience. Patients, caregivers, healthcare professionals, and donors: find information, news, and services more easily.
Launch of a new Interuniversity Diploma (DIU) in Personalized Cancer Prevention under the auspices of the Universities of Paris-Saclay, Rennes, and Lyon 1
The Universities of Paris Saclay, Rennes, and Lyon 1; Gustave Roussy, the Eugène Marquis and Léon Bérard Centers; the national Interception program, the national Cancept network, and the PRISM Institute announce the launch of a new Inter-University Diploma (DIU) dedicated to personalized cancer prevention.
On
Personalized cancer prevention has become a central issue in public health and the fight against cancer. It complements primary and secondary prevention efforts to reduce cancer mortality and also helps combat the significant rise in the incidence of certain cancers linked to aging, individual risk, and specific exposures.
The new roadmap for the 2026–2030 Ten-Year Cancer Control Strategy calls for more personalized screening strategies, tailored to specific regions and social contexts, different age groups, and individual risk of developing cancer.
Given the rise of this new form of prevention, it is essential in France to train healthcare and research professionals, as well as those involved in healthcare organization.
The Inter-University Diploma (DIU) in Personalized Cancer Prevention aims to equip professionals with the knowledge and skills necessary to implement these new approaches to personalized cancer prevention: foundational concepts, existing scientific data, the practical application of this prevention with patients, and the medical, scientific, ethical, and psychosocial challenges involved, as well as the knowledge required for research and development in this field.
Target Audience:
- Healthcare professionals who are currently involved in or wish to develop a practice in cancer prevention: oncologists, general practitioners, and specialists (gynecologists, hepatogastroenterologists, nutritionists, addiction specialists, public health specialists, oncogeneticists, etc.), pharmacists, nurses, midwives
- Healthcare administration professionals, professionals in the healthcare industry
- Researchers and/or students in fields related to cancer prevention and health promotion
- Expert patients
Program highlights: 10 modules
- Concepts
- Identifying individuals at high risk for cancer
- Care pathways, current and future tools for personalized prevention
- Science and research in cancer prevention—biological foundations of personalized prevention
- Personalized prevention in practice: what level of evidence is needed in which situations
- Major Interventions in Personalized Prevention
- Clinical, Interventional, and Translational Research in Personalized Prevention
- Personalized Cancer Prevention: The Individual in Their Environment
- Ethical Considerations and Equity
- Certification Module
Format: 100 hours of coursework, a combination of in-person (2 days) and online (Fridays) sessions between November 2026 and June 2027
Registration open until September 15
Course start date: November 2026
Press contact
If you are a journalist and have a question, please contact:
Claire Parisel or Léona Pinto
Tel. +33 1 42 11 50 59
Tel. +33 1 42 11 63 59
Mob. +33 6 17 66 00 26
Email
The Media Team cannot respond to patient inquiries.
Last press releases
-
Gold september: two new research programmes launched to tackle childhood cancers
Two of Gustave Roussy’s four new medical and scientific programmes are dedicated to childhood cancers. The first, DECRIPT, aims to improve understanding of the role played by genetics in the development of certain childhood cancers, as well as second cancers that may occur in adulthood. The second, INSPIRE, will draw on the knowledge and techniques already developed at the Institute to create organoids, with the aim of deciphering the mechanisms underlying metastasis and resistance to treatment.
-
Prof. Fabrice Barlesi reappointed at the head of Gustave Roussy, the leading cancer center in France and Europe
By order of Ms. Stéphanie Rist, Minister of Health, Families, Autonomy and Persons with Disabilities, dated 27 July 2026, Professor Fabrice Barlesi has been reappointed as Director General of Gustave Roussy, effective 1 August 2026. At the helm of the Institute for five more years, Prof. Barlesi will continue the transformations undertaken during his first term. This renewal reflects the confidence placed in the project led by the institution to accelerate progress in the fight against cancer, foster and support the development of innovations set to change the future of oncology, and strengthen the influence of one of the world's leading cancer centers.
-
Route du Rhum 2026 Jean Le Cam and Christophe Rateau to sail for Gustave Roussy
For the Route du Rhum - Destination Guadeloupe 2026, Jean Le Cam and Christophe Rateau will sail under the colors of Gustave Roussy, the leading cancer center in France and Europe. Competing respectively in the Vintage and Class40 categories, the two skippers will carry the Institute's mission to the general public, supporting cancer research and raising awareness of prevention, innovation and patient care.
-
Owkin and Gustave Roussy partner to bring K Pro into real-world clinical practice
Owkin and Gustave Roussy, Europe's leading cancer center, today announced a partnership to test K Pro directly within the hospital's real-world clinical and research workflows.
